Literature DB >> 9454608

Interaction of adrenodoxin with P4501A1 and its truncated form P450MT2 through different domains: differential modulation of enzyme activities.

H K Anandatheerthavarada1, S Addya, J Mullick, N G Avadhani.   

Abstract

Recently we showed that the beta-naphthoflavone-inducible liver mitochondrial P450MT2 consists of two N-terminal truncated forms of the microsomal P4501A1, termed P450MT2a (+5/1A1) and MT2b (+33/1A1) [Addya et al. (1997) J. Cell Biol. 139, 589-599]. In the present study, we demonstrate that intact P4501A1 and the major mitochondrial form, P450MT2b (routinely referred to as P450MT2), show distinct substrate specificities and preference for different electron transport proteins. Enzyme reconstitution and spectral studies show that the wild-type adrenodoxin (Adx), but not the mutant Adx, binds to P450MT2 in a functionally productive manner (Kd = 0.6 microM) and induces a characteristic high-spin state. Adx binding to intact P4501A1 or +5/1A1 is less efficient as seen from spectral shift patterns (Kd = 1.8-2.0 microM) and reconstitution of enzyme activity. Use of Adx--Sepharose affinity matrix yielded < 90% pure P450MT2 (specific activity: 13.5 nmol/mg of protein) starting from a partially purified fraction of 10-15% purity, further demonstrating the specificity of P450MT2 and Adx interaction. Chemical cross-linking studies show that the bovine Adx forms heteroduplexes with both P450MT2 and intact P4501A1, though at different efficiencies. Our results show that Adx interacts with P450MT2 through its C-terminal acidic domain 2, while interaction with intact P4501A1 likely involves the N-terminal acidic domain 1. These results point to an interesting possibility that different electron transfer proteins may differently modulate the enzyme activity. Our results also demonstrate for the first time as to how a different mode of Adx interaction differently modulates the substrate specificities of the two P450 forms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454608     DOI: 10.1021/bi972046j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Evolutionarily divergent electron donor proteins interact with P450MT2 through the same helical domain but different contact points.

Authors:  H K Anandatheerthavarada; G Amuthan; G Biswas; M A Robin; R Murali; M R Waterman; N G Avadhani
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 2.  Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.

Authors:  Michelle C Sangar; Seema Bansal; Narayan G Avadhani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

3.  Accumulation of mitochondrial P450MT2, NH(2)-terminal truncated cytochrome P4501A1 in rat brain during chronic treatment with beta-naphthoflavone. A role in the metabolism of neuroactive drugs.

Authors:  E Boopathi; H K Anandatheerthavarada; S V Bhagwat; G Biswas; J K Fang; N G Avadhani
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

4.  Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease.

Authors:  Prachi Bajpai; Michelle C Sangar; Shilpee Singh; Weigang Tang; Seema Bansal; Goutam Chowdhury; Qian Cheng; Ji-Kang Fang; Martha V Martin; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

5.  Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins.

Authors:  Hongbin Dong; Howard G Shertzer; Mary Beth Genter; Frank J Gonzalez; Vasilis Vasiliou; Colin Jefcoate; Daniel W Nebert
Journal:  Biochem Biophys Res Commun       Date:  2013-05-18       Impact factor: 3.575

Review 6.  Roles of Cytochrome P450 in Metabolism of Ethanol and Carcinogens.

Authors:  F Peter Guengerich; Narayan G Avadhani
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.